New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
Pharmaceutical Daily,
Interim results from FINE-REAL, a prospective, observational study evaluating clinical characteristics and treatment patterns…